泰坦科技688133 时间: 2025年7月8日星期二 64.15分综合得分 较强 趋势方向 主力成本分析 24.74 元 当日主力成本 23.84 60日主力成本 周期内涨跌停 过去一年内该股 涨停 元 5日主力成本 22.51 元 20日主力成本 22.90 元 0次 次 北向资金数据 持股量75.44万股 占流通比0.45% 昨日净买入-1.35万股 昨日增仓比-0.008% 5日增仓比-0.111% 20日增仓比-0.495% 跌停 0 技术面分析 23.96 短期压力位 23.26 短期支撑位 23.96 中期压力位 21.02 中期支撑位 股价突破短期压力位，短线有望走强； 股价突破中期压力位，中线有望走强 K线形态 暂无特殊形态 资金流数据 2025年07月08日的资金流向数据方面 主力资金净流入1996.71万元 占总成交额22% 超大单净流入758.93万元 大单净流入1237.77万元 散户资金净流入32.44万 关联行业/概念板块 专业服务 1.31%等 财务数据 最近的财报数据显示，该股于2025年07月08日 每股收益0.03元 营业利润0.02亿元 市盈率--- 销售毛利率23.2 ...

中信证券股份有限公司 关于上海泰坦科技股份有限公司 使用部分闲置募集资金暂时补充流动资金之核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐机构"）作为上海 泰坦科技股份有限公司（以下简称"泰坦科技"或"公司"）2021 年度向特定 对象发行股票的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券 交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》《上市公司募集资金监管规则》等有关法律法规和规范性文 件的要求，对泰坦科技拟使用部分闲置的 2021 年度向特定对象发行 A 股股票募 集资金暂时补充流动资金的事项进行了认真、审慎的核查，发表如下意见： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意上海泰坦科技股份有限公司向特定 对象发行股票注册的批复》（证监许可〔2022〕871 号），上海泰坦科技股份有 限公司向特定对象发行 A 股股票 7,624,896 股，发行价格为人民币 131.61 元/股， 本次发行的募集资金总额为人民币 1,003,512,562.56 元，扣除相关发行费用人民 币 18,328,561.10 元，募集资金净额为 ...

重要内容提示： 证券代码：688133 证券简称：泰坦科技 公告编号：2025-028 上海泰坦科技股份有限公司 关于使用部分闲置募集资金暂时补充流动资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 截至 2025 年 5 月 30 日，上海泰坦科技股份有限公司（以下简称"公司" "泰坦科技"）已提前将于 2025 年 6 月 13 日到期的前次用于暂时补充流动资金 的 15,000 万元提前全部归还至募集资金专用账户，并将上述募集资金的归还情况 通知了公司的保荐机构及保荐代表人； 2025 年 6 月 27 日，公司召开了第四届董事会第十六次会议、第四届监 事会第十五次会议，审议通过了《关于使用部分闲置募集资金暂时补充流动资金 的议案》。根据募集资金投资项目的资金使用计划及项目的建设进度，在确保不 影响募集资金投资项目建设进度的前提下，为提高募集资金使用效率，减少公司 财务费用，降低公司运营成本，公司拟使用额度不超过人民币 15,000.00 万元 （含本数）的闲置的 2021 年度向特定对象发行 A 股股票募 ...

证券代码：688133 证券简称：泰坦科技 公告编号：2025-027 第四届监事会第十五次会议决议公告 上海泰坦科技股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况： 上海泰坦科技股份有限公司（以下简称"公司"）第四届监事会第十五次会 议通知已于 2025 年 6 月 18 日以书面方式送达全体监事，会议于 2025 年 6 月 27 日在上海市徐汇区石龙路 89 号会议室召开，本次会议由监事会主席顾梁先生召 集并主持，应到监事 3 人，实到监事 3 人。本次会议的召集和召开符合《中华人 民共和国公司法》（以下简称"《公司法》"）和《上海泰坦科技股份有限公司 章程》（以下简称"《公司章程》"）等相关规定，会议形成的决议合法、有效。 二、监事会会议审议情况： 与会监事就如下议案进行了审议，并表决通过以下事项： 1、审议通过《关于使用部分闲置募集资金暂时补充流动资金的议案》 具体内容详见同日刊载于上海证券交易所网站（www.sse.com.cn）的公司《关 于使用部分闲置募集资金暂时补充流 ...

Core Viewpoint - Titan Technology has established a smart production base in Yichang, Hubei, which represents a significant shift in China's scientific service industry, moving from reliance on imported reagents and equipment to a strong domestic presence [1][2]. Company Development - Titan Technology was founded by a group of university students aiming to provide better services for laboratories, focusing on the reliability of reagents and equipment [2][3]. - The company received initial funding of 200,000 yuan from the Shanghai University Student Science and Technology Entrepreneurship Fund, which has supported numerous entrepreneurial projects since its inception in 2006 [2]. Business Strategy - The company has shifted its strategy from merely pursuing scale to focusing on profitability, with a significant increase in the sales and gross margin of its proprietary brands [4][5]. - In 2024, the sales revenue from proprietary brands accounted for 63.23% of total sales, with a gross margin of 84.74%, indicating a strong competitive position in the market [4]. Mergers and Acquisitions - Titan Technology has actively pursued mergers and acquisitions to expand its proprietary brand portfolio, completing acquisitions of three companies and establishing two joint ventures in 2024 [5][6]. - The acquisition of Anhui Tiandi High-Purity Solvent Co., Ltd. significantly increased its production capacity from 3,800 tons to 13,800 tons after modernization [5]. Product Development - The company has launched new high-end scientific instruments, such as the IVScope8000Pro small animal imaging system, and developed gold standard chromatographic solvents, which have received positive market feedback [6][7]. - The gold standard chromatographic solvents have been upgraded to significantly reduce impurities, meeting or exceeding the standards of imported brands [6]. Digital Transformation - Titan Technology emphasizes digitalization and modeling in its operations to enhance efficiency and reduce costs, including the development of an intelligent warehousing and logistics system [7][8]. - The company has implemented a full inventory QR code digital management system, improving inventory management efficiency and traceability [7]. Future Outlook - The smart production base is designed to operate with minimal human intervention, utilizing advanced AI algorithms for real-time data analysis and predictive maintenance, which will enhance product quality and operational efficiency [8].

Core Points - The company announced a cash dividend of RMB 0.07 per share, totaling RMB 11,510,588.39 for all shareholders [1] - The profit distribution plan was approved at the annual shareholders' meeting on May 20, 2025 [1] - The dividend will be distributed based on the total share capital of 164,436,977 shares [1] Distribution Details - The cash dividend will be distributed to shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the record date [1] - The actual cash dividend after tax for individual shareholders holding shares for less than one year is RMB 0.07 per share, while those holding for over one year are exempt from personal income tax [2] - For Qualified Foreign Institutional Investors (QFII), the after-tax cash dividend is RMB 0.063 per share due to a 10% withholding tax [3][4] Taxation Information - Individual shareholders holding shares for less than one month will incur a 20% tax on dividends, while those holding between one month and one year will incur a 10% tax [2] - Other corporate shareholders are responsible for their own tax declarations, with a pre-tax dividend of RMB 0.07 per share [4]

证券代码：688133 证券简称：泰坦科技 公告编号：2025-026 上海泰坦科技股份有限公司 2024年年度权益分派实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： | 股权登记日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | | 2025/6/19 | 2025/6/20 | 2025/6/20 | 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025年 5月 20 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任 公司上海分公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 3. 分配方案： 本次利润分配以方案实施前的公司总股本164,436,977股为基数，每股派发现 是否涉及差异化分红送转：否 每股分配比例 每股现金红利0.07元 相关日期 1. 发放年度：2024年年度 2. 分派对象： 金红利0.07元（含税），共计派发现金红利11,510,588 ...

Group 1 - The stock of Titan Technology (688133) has a comprehensive score of 49.17, indicating a weak performance [1] - The main cost analysis shows the following prices: current main cost at 22.40 CNY, 5-day main cost at 22.49 CNY, 20-day main cost at 22.15 CNY, and 60-day main cost at 23.18 CNY [1] - There have been no instances of the stock hitting the upper limit or lower limit in the past year [1] Group 2 - The short-term pressure level is at 22.64 CNY, while the short-term support level is at 22.26 CNY [2] - The stock is currently experiencing unclear short-term and mid-term trends, awaiting direction from main funds [2][3] - The financial data indicates earnings per share of 0.03 CNY, operating profit of 0.02 billion CNY, and a net profit of 1,855,610.93 CNY [2]

Core Insights - The article discusses the collaboration between government and enterprises in Shanghai, Zhejiang, and Anhui to promote the development of the high-end analytical testing reagent industry chain, marking a shift towards domestic production and reducing reliance on international giants [1][2]. Group 1: Industry Overview - The high-end analytical testing reagent market has been dominated by international companies, with over 80% market share held by foreign firms [1]. - Titan Technology, founded in 2007, has successfully overcome key challenges such as quality issues and reliance on core technologies, enabling the production of high-purity deuterated solvents domestically [1][2]. Group 2: Regional Collaboration - The signing ceremony involved market regulatory departments from Shanghai, Zhejiang, and Anhui, focusing on enhancing quality construction, standard cooperation, brand cultivation, and talent development within the industry [2][3]. - The collaboration aims to create a closed-loop ecosystem that integrates detection, research and development, and production, facilitating the industrialization of domestic alternatives [2][3]. Group 3: Product Innovation - Titan Technology launched five innovative products during the signing ceremony, covering analytical reagents, biological reagents, testing consumables, laboratory equipment, and intelligent laboratory systems [3]. - The company has achieved over 95% domestic substitution for laboratory products, with more than 7 million SKUs available on its sales platform [3].

Core Insights - The signing ceremony for "Quality Collaborative Improvement of High-end Analytical Testing Reagents Industry Chain" was held, aiming to break the long-standing monopoly of international giants in the domestic scientific reagent market, where over 80% is controlled by foreign companies [1][3] - The domestic high-end analytical testing reagent market has seen an average annual growth rate of 20% from 2020 to 2023, but faces challenges such as high dependence on imports for key raw materials and equipment [2][3] - Titan Technology has invested in Cuiying Chemical Technology, which is currently the only domestic company capable of mass-producing deuterated reagents, achieving a domestic market share of approximately 25% [2][3] Industry Developments - The collaboration among the market regulatory departments of Shanghai, Zhejiang, and Anhui focuses on four key areas: industry chain quality construction, standard establishment cooperation, brand cultivation, and quality talent development [3][4] - The production of deuterated reagents is complex, with factors like water, oxygen, and temperature affecting quality, necessitating the resolution of key technical issues [2][3] - The signing aims to create an ecosystem that connects detection, research and development, and production, enhancing the overall quality of the high-end analytical testing reagent industry [3][5] Market Dynamics - The domestic market for deuterated reagents was previously entirely reliant on imports, but with advancements in local production capabilities, there is a shift towards domestic alternatives [2][3] - Titan Technology's comprehensive product system includes reagents, instruments, consumables, e-commerce platforms, and smart laboratory solutions, providing full-process support for technology companies [3][5] - The collaboration is expected to facilitate the export of domestic reagent products, transitioning from domestic substitution to global reverse export [3][4]